Expanded access program (EAP) to investigational drugs.

被引：0
|
作者：
Talarico, L [1 ]
Pazdur, R [1 ]
机构：
[1] US FDA, Rockville, MD 20857 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6001
引用
收藏
页码：519S / 519S
页数：1
相关论文
共 50 条
  • [41] Italian nivolumab Expanded Access Program (EAP) in melanoma adjuvant setting: Patients outcomes and safety profile
    Del Vecchio, M.
    Di Giacomo, A. M.
    Quaglino, P.
    Sileni, V. Chiarion
    Queirolo, P.
    De Galitiis, F.
    Cognetti, F.
    Mandala', M.
    Guidoboni, M.
    Rinaldi, G.
    Depenni, R.
    Consoli, F.
    Troiani, T.
    Guida, M.
    Marconcini, R.
    Ferrucci, P. F.
    Bersanelli, M.
    Rossi, E.
    Aglietta, M.
    Ascierto, P. A.
    ANNALS OF ONCOLOGY, 2021, 32 : S890 - S891
  • [42] Implementation of Tofersen Expanded Access Program (EAP) in the US, The Cumulative Experience of Six Academic Centers.
    Ajroud-Driss, Senda
    Babu, Suma
    Harms, Matthew
    Shneider, Neil
    Quinn, Colin
    Arcila-Londono, Ximena
    Bucelli, Robert
    MUSCLE & NERVE, 2023, 68 : S59 - S60
  • [43] Cabozantinib in metastatic renal cell carcinoma (mRCC): Data from UK expanded access program (EAP)
    Lista, A. Gomez de Liano
    Venugopal, B.
    Fife, K.
    Symeonides, S.
    Vasudev, N. S.
    Rudman, S. M.
    Vohra, S.
    Khasati, L.
    Pettinger, C.
    Szabados, B.
    Morrison, L.
    Powles, T.
    Boleti, E.
    ANNALS OF ONCOLOGY, 2018, 29 : 317 - 317
  • [44] Ensuring Justice in Access to Investigational Neurological Drugs
    Kearns, Lisa
    Bateman-House, Alison
    Caplan, Arthur
    SEMINARS IN NEUROLOGY, 2018, 38 (05) : 583 - 588
  • [45] THE PARALLEL TRACK FOR ACCESS TO INVESTIGATIONAL NEW DRUGS
    GINZBURG, HM
    PEDIATRIC AIDS AND HIV INFECTION-FETUS TO ADOLESCENT, 1992, 3 (03): : 120 - 123
  • [46] Access to 'investigational' cancer drugs: perspective of a trainee
    Kuo, J. C.
    INTERNAL MEDICINE JOURNAL, 2015, 45 (02) : 235 - 235
  • [47] Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP).
    Hassel, Jessica Cecile
    Forschner, Andrea
    Blum, Leonie
    Heinzerling, Lucie
    Zimmer, Lisa
    Utikal, Jochen
    Kahler, Katharina C.
    Schlaak, Max
    Loquai, Carmen
    Gutzmer, Ralf
    Kiecker, Felix
    Berking, Carola
    Bender, Armin
    Schneider, Lars
    Enk, Alexander
    Garbe, Claus
    Weichenthal, Michael
    Schadendorf, Dirk
    Hauschild, Axel
    Mohr, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] The Role of Physicians in Expanded Access to Investigational Drugs: A Mixed-Methods Study of Physicians' Views and Experiences in The Netherlands
    Bunnik, Eline M.
    Aarts, Nikkie
    JOURNAL OF BIOETHICAL INQUIRY, 2021, 18 (02) : 319 - 334
  • [49] Expanded Access of Investigational Drugs: The Experience of the Center of Drug Evaluation and Research Over a 10-Year Period
    Jarow, Jonathan P.
    Lemery, Steven
    Bugin, Kevin
    Khozin, Sean
    Moscicki, Richard
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (06) : 705 - 709
  • [50] The Role of Physicians in Expanded Access to Investigational Drugs: A Mixed-Methods Study of Physicians’ Views and Experiences in The Netherlands
    Eline M. Bunnik
    Nikkie Aarts
    Journal of Bioethical Inquiry, 2021, 18 : 319 - 334
12345